109 related articles for article (PubMed ID: 19643193)
1. Finding and killing the CRABs of pancreatic cancer.
Caldwell ME; Tuveson DA
Gastroenterology; 2009 Sep; 137(3):782-5. PubMed ID: 19643193
[No Abstract] [Full Text] [Related]
2. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.
Mueller MT; Hermann PC; Witthauer J; Rubio-Viqueira B; Leicht SF; Huber S; Ellwart JW; Mustafa M; Bartenstein P; D'Haese JG; Schoenberg MH; Berger F; Jauch KW; Hidalgo M; Heeschen C
Gastroenterology; 2009 Sep; 137(3):1102-13. PubMed ID: 19501590
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
4. [Updates on study of glioma stem cells].
Zhou ZH; Yi L; Bian XW
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):201-3. PubMed ID: 17535692
[No Abstract] [Full Text] [Related]
5. Cancer stem cells and tumor metastasis: first steps into uncharted territory.
Dalerba P; Clarke MF
Cell Stem Cell; 2007 Sep; 1(3):241-2. PubMed ID: 18371356
[TBL] [Abstract][Full Text] [Related]
6. mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.
Matsubara S; Ding Q; Miyazaki Y; Kuwahata T; Tsukasa K; Takao S
Sci Rep; 2013 Nov; 3():3230. PubMed ID: 24231729
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?
Habib M; Saif MW
JOP; 2013 Jul; 14(4):401-4. PubMed ID: 23846937
[TBL] [Abstract][Full Text] [Related]
8. [An update: stem cell and cancer stem cells].
Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
[No Abstract] [Full Text] [Related]
9. Targeting pancreatic cancer stem cells for cancer therapy.
Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
11. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.
Hermann PC; Huber SL; Herrler T; Aicher A; Ellwart JW; Guba M; Bruns CJ; Heeschen C
Cell Stem Cell; 2007 Sep; 1(3):313-23. PubMed ID: 18371365
[TBL] [Abstract][Full Text] [Related]
12. Cancer: stem cells and brain tumours.
Dirks PB
Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
[No Abstract] [Full Text] [Related]
13. Cancer stem cells: a novel paradigm for cancer prevention and treatment.
Subramaniam D; Ramalingam S; Houchen CW; Anant S
Mini Rev Med Chem; 2010 May; 10(5):359-71. PubMed ID: 20370703
[TBL] [Abstract][Full Text] [Related]
14. Biology and clinical applications of pancreatic cancer stem cells.
Abel EV; Simeone DM
Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.
Garrido-Laguna I; Hidalgo M
Nat Rev Clin Oncol; 2015 Jun; 12(6):319-34. PubMed ID: 25824606
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
[TBL] [Abstract][Full Text] [Related]
17. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies.
Adsay NV
Surgery; 2003 May; 133(5):459-63. PubMed ID: 12773972
[No Abstract] [Full Text] [Related]
18. Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?
Neuzil J; Stantic M; Zobalova R; Chladova J; Wang X; Prochazka L; Dong L; Andera L; Ralph SJ
Biochem Biophys Res Commun; 2007 Apr; 355(4):855-9. PubMed ID: 17307142
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
20. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.
Zhang Q; Shi S; Yen Y; Brown J; Ta JQ; Le AD
Cancer Lett; 2010 Mar; 289(2):151-60. PubMed ID: 19748175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
